A study on the effect of Janaranjanakam Anjana in the management of Senile Immature Cataract

Abstract

Senile cataract is an important cause of age dependent visual impairment and blindness. Till date, an effective medical treatment for senile cataract has not been found out. The only treatment of choice is surgery. Considering the increased rate of incidence of senile cataract, on availability of effective medical measures, possible complications and contraindications surgery, the need arises to research for drugs that could effectively help in arresting the progression and disintegrate the opacification of lens proteins. The Symptoms such as blurriness of vision, Glare, Diplopia etc. are mentioned in senile immature cataract which can be correlated with Kaphaja Timira. Objective of the study was to evaluate the efficacy of Janaranjanakam Anjana and Vimalanjana in the management of SIMC and to compare the efficacy of Janaranjanakam Anjana and Vimalanjana in the management of SIMC. In present study 40 patients were randomly selected and divided into 2 groups, with 20 patients each. Group A patients were treated with Janaranjanakam Anjana for 60 days. Group B were treated with Vimalanjana for 60 days. After the treatment it was observed that there was statistically significant result in the main signs and symptoms i.e. blurring of vision, floaters, glare, visual acuity for distant and near vision and slit lamp bio-microscopy. Amongst 40 patients, 1 patient were getting no improvement, 12 patients were getting Mild improvement, 23 patients were getting Moderate improvement and 4 patients were getting Marked improvement.